More recent work demonstrated that GS-1101 completely blocks survival signals mediated by BCR engagement and significantly reduces survival of CLL cells cultured on specialized nurse-like cells (NLC) derived from peripheral blood monocytes (Hoellenriegel et al., 2011). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.